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Abstract
Objective—To examine the association between overweight and obesity and serum ferritin 
among women of reproductive age (15–49 years) in Nicaragua, considering the effect of α1-acid 
glycoprotein (AGP), a marker of inflammation.
Design—We analysed data from the 2004–05 Nicaraguan Integrated Surveillance System for 
Nutrition Interventions. Three logistic regression models were analysed with low serum ferritin 
(<15 μg/l) as the dependent variable: (i) overweight or obese status and covariates; (ii) model 1 
plus AGP; and (iii) model 1 restricted to only women with normal AGP levels (≤1·0 g/l).
Setting—Nicaragua.
Subjects—Included in this analysis were 832 non-pregnant mother/caregivers (15–49 years) 
surveyed in 2004–2005.
Results—In the sample, prevalence of overweight and obesity was 31·8 % and 19·2 %, 
respectively, and 27·6 % had low serum ferritin. In model 1, the adjusted OR of low serum ferritin 
was 0·74 (95 % CI 0·52, 1·05) for overweight women and 0·42 (95 % CI 0·26, 0·65) for obese 
women. In model 2, AGP was significantly independently associated with low serum ferritin 
(adjusted OR=0·56, 95 % CI 0·34, 0·92) while the adjusted OR for overweight and obesity were 
largely unchanged. Excluding women with elevated AGP did not appreciably affect the 
relationship between overweight or obesity and low serum ferritin (model 3).
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Conclusions—Overall, in this population of reproductive-age women, obese women were less 
likely to have low serum ferritin levels, and this was independent of inflammation as measured by 
AGP.
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Anaemia is one of the most common nutritional disorders, affecting an estimated 1·62 
billion people around the globe(1). Fe deficiency is an important cause of anaemia, but can 
also be present without anaemia. Fe deficiency is also highly prevalent globally and non-
pregnant women of reproductive age (15–49 years) are greatly affected, with over 496 
million(2) identified as Fe deficient worldwide. Anaemia and Fe deficiency are associated 
with impaired cognitive function and decreased work capacity(3). For women of 
reproductive age who may become pregnant, additional adverse effects include increased 
risk for preterm delivery, low-birth-weight infants and decreased Fe stores for the baby, 
which may lead to impaired development(4). Populations in developing countries are 
particularly susceptible to anaemia and Fe deficiency due to increased risk of infections and 
poor diet quality(3).
There is uncertainty regarding the ideal biomarkers to assess Fe status during states of 
infection and/or inflammation(5). Serum ferritin is greatly affected by increased 
inflammation, while other Fe status markers such as soluble transferrin receptor, Zn 
protoporphyrin and erythropoietin may be less affected, although these indicators have other 
drawbacks(6). Serum ferritin is the WHO-recommended indicator to assess Fe deficiency in 
populations in the absence of inflammation. However, there is no clear guidance on how to 
account for inflammation in assessing Fe status in populations with a high prevalence of 
inflammation(7).
Concurrently, overweight and obesity have become a global epidemic with over a third of 
adult women considered overweight or obese and almost two-thirds in central Latin 
America(8,9). A growing number of developing countries are experiencing a dual burden of 
malnutrition with undernutrition and overnutrition present at the same time(10–13). Obesity is 
associated with CVD, diabetes and some cancers(14). In addition, obesity, anaemia and Fe 
deficiency can result in overlapping consequences, including adverse pregnancy 
outcomes(4,15). Using various indicators of Fe status to define Fe deficiency, several reports 
have found an association between obesity and Fe deficiency, with the direction of the 
relationship varying by the Fe indicator used(16–22). Serum ferritin is often used as a 
biomarker for detecting Fe deficiency in epidemiological studies since low serum ferritin 
levels are a reflection of depleted Fe stores(3). Multiple studies, most carried out in high-
income countries, have reported positive(18,23,24) or non-significant associations(22,25–27) 
between serum ferritin and obesity or overweight status. This may be due to increased 
inflammation associated with obesity(28) and ferritin’s role as an acute-phase protein(18,29). 
This is in contrast to other indicators that detect later stages of Fe deficiency (e.g. soluble 
transferrin receptor, serum Fe, transferrin saturation), which tend to show an inverse 
relationship between Fe status and weight status(16–18,20,22,30,31).
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During an acute-phase response, the concentration of positive acute-phase proteins increases 
and may lead to a decrease in Hb production and an increase in serum ferritin(32,33), 
although the exact mechanism of this increase remains unclear(34). C-reactive protein (CRP) 
and α1-acid glycoprotein (AGP) are commonly used to measure the acute-phase response 
caused by inflammation(35). Both of these indicators have been positively associated with 
obesity(31) and elevated serum ferritin(7). CRP has been frequently used to measure 
inflammation in overweight and obese populations(16–18,21,31,36), although AGP, a marker of 
chronic low-grade inflammation, may be a more appropriate indicator for assessing the 
chronic inflammation associated with obesity(6). The use of CRP as a marker of acute 
inflammation and AGP as a marker of chronic inflammation is based on the behaviours of 
these proteins in response to an acute or chronic infection(37). The behaviours of these 
proteins in response to chronic excess of adipose tissue and elevation of adipokines have 
been less studied, although it appears they are associated(38).
In developing countries where the double burden of undernutrition and overnutrition is 
increasing, understanding the potential influence of overweight and obesity on serum 
ferritin, a key indicator of Fe deficiency, may be important to understand the prevalence of 
and changes in Fe deficiency in these countries over time. The objective of the current 
analysis was to examine the relationship between overweight and obesity and serum ferritin 
among a population of women of reproductive age from Nicaragua. We also consider the 
impact of AGP on these relationships.
Experimental methods
Participants
In Nicaragua, the Sistema Integrado de Vigilancia de Intervenciones Nutricionales (SIVIN; 
Integrated Surveillance System for Nutrition Interventions) surveys a nationally 
representative sample of households with children 6–59 months of age. SIVIN employs a 
complex, multistage, probability cluster design to continuously sample selected households 
throughout the year, resulting in a national sample after 12 months of data collection; 
multiple years can be combined for increased sample size. In each household, a single child 
(6–59 months) as well as his/her mother or caregiver are invited to participate. The 
participants included in the current analysis were the non-pregnant mother/caregivers (aged 
15–49 years) surveyed in 2004–2005. These women reported information about the 
household, family, herself and her child; anthropometric and biological measures were also 
collected.
Ethical review
Participation in the interview and biological sample collection was voluntary and informed 
consent by signature was obtained from each woman. The Nicaraguan Ministry of Health 
approved the data collection. A de-identified data set was used for the current analysis. 
Emory University Institutional Review Board (IRB) determined no IRB review was required 
for this secondary analysis.
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Height and weight measurements were taken according to recommended standards(39). Shorr 
measuring boards were used to measure each woman’s height in centimetres and 
millimetres. Weight was measured by SECA 881 scales in kilograms. BMI (kg/m2) values 
were categorized as: underweight (<18·5), normal weight (18·5–24·9), overweight (25·0–
29·9) and obese (≥30·0)(40). Weight values of <12·9kg or >140·0 kg, height values of <110·0 
cm or >200·0 cm and BMI values of <3·2kg/m2 or >55·0kg/m2 were excluded as 
implausible(41).
Biochemical measures
Venous sampling was used to collect blood samples. Vacutainers were placed in a cold box 
during the day and processed each night. After processing, samples were frozen and stored 
in freezers in the health clinic until being transported to the central laboratory within a few 
days. Samples were then shipped to the Instituto de Nutricion de Centro America y Panama 
(INCAP) in Guatemala for analysis of AGP and serum ferritin. Serum AGP was measured 
by the Dade-Behring turbidimetric method(41) and serum ferritin by the Ramco enzymatic 
immunoassay. Elevated AGP was defined as >1·0 g/l(42) and low serum ferritin as <15 μg/
l(43).
Covariates
Covariates included age (15·0–19·9 years, 20·0–29·9 years, 30·0–39·9 years and 40·0–49·9 
years), urban/rural residence, and education attained (none, primary school, secondary 
school, university).
Statistical analyses
From 2004–2005, 1000 women were surveyed. Analysis was limited to participants with 
complete data for serum ferritin, AGP, anthropometry and covariates (n 861). Those 
excluded because of insufficient data were more likely to be older (40·0–49·9 years) and 
with no formal education. Underweight women were excluded from analysis due to small 
sample size (n 29). This brought the final sample size to 832. Descriptive statistics and the 
prevalence of low serum ferritin in each BMI and AGP group were calculated. Normality 
assessment showed AGP and serum ferritin to have non-normal distributions; therefore 
geometric means were presented and Pearson correlations used log-transformed variables.
Logistic regression modelling was implemented accounting for weighting and complex 
sample design using the procedure SURVEYLOGISTIC in the statistical software package 
SAS version 9·2. Collinearity was assessed by a macro accounting for sample design using 
PROC SURVEYLOGISTIC (M Zack, J Singleton, C Satterwhite et al., unpublished results). 
Three models with low serum ferritin as the dependent variable and categorized BMI as the 
primary independent variable were analysed. The first model included only the weight status 
variables and covariates, the second model additionally adjusted for AGP, and the third 
model was the same as the first model except that the sample was limited to only those 
participants without elevated AGP (n 663). All models were adjusted for age, urban/rural 
residence and education. Interactions were assessed for weight status with each covariate 
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and considered significant at P<0·05. In the primary model the interaction between age and 
weight status was statistically significant but was dropped because of the low sample size in 
one subset (n 4). No other two-way interactions were significant.
Results
As shown in Table 1, 49·0 % of the women in the final sample were categorized as normal 
weight, 31·8% as overweight and 19·2 % as obese, with mean BMI of 26·1 (95 % CI 25·7, 
26·4) kg/m2. Obese and overweight women were more likely to have elevated AGP levels. 
Only 15·4% of normal-weight women had elevated AGP compared with 22·7 % of 
overweight and 29·6 % of obese women (P<0·0001). The geometric mean of AGP among 
the women was 0·82 (95 % CI 0·80, 0·84) g/l (data not shown).
Just over a quarter of women had low serum ferritin (Table 1) with a geometric mean of 
26·1 (95 % CI 24·3, 28·1) μg/l. Overweight (26·4 %) and obese (17·0%) women were less 
likely to have low serum ferritin compared with normal-weight women (32·6 %; Table 2), 
with crude prevalence odds ratio for overweight v. normal weight of 0·74 (95 % CI 0·54, 
1·03) and obese v. overweight of 0·42 (95 % CI 0·27, 0·65; Table 1). Serum ferritin and 
AGP were both significantly correlated with BMI and with each other, with Pearson’s r of 
0·20–0·22 (means and correlation data not shown).
In order to explore the effect of inflammation (AGP) and weight status on low serum 
ferritin, three models were constructed. In the first model, all women were included 
(elevated and normal AGP). Only obese status was a significant predictor of low serum 
ferritin with an adjusted odds ratio (AOR) of 0·42 (95 % CI 0·26, 0·65). In the second 
model, AGP was included and was significantly associated with low serum ferritin with 
AOR of 0·56 (95 % CI 0·34, 0·92). However, the relationship between weight status and 
serum ferritin remained largely unchanged with an overweight AOR of 0·77 (95 % CI 0·54, 
1·10) and an obese AOR of 0·45 (95 % CI 0·28, 0·71). In the third model, all women with 
elevated AGP (n 169) were excluded from the analysis. This also had little effect on the 
relationship between weight status and serum ferritin. Overweight women had an OR of 
0·69 (95 % CI 0·47, 1·03) and obese women had an OR of 0·39 (95 % CI 0·22, 0·67; Table 
3). Overall, women with a BMI≥30·0 kg/m2 were significantly less likely to have low serum 
ferritin. This relationship was not appreciably affected when accounting for inflammation as 
indicated by AGP.
Discussion
Low serum ferritin and obesity were significantly inversely associated in this nationally 
representative sample of non-pregnant, reproductive-age women with children under 5 years 
in Nicaragua, indicating that obese women were less likely to have low serum ferritin levels 
(an indicator of Fe deficiency) when compared with normal-weight women. Age, region and 
education did not modify or confound this relationship nor independently predict Fe status. 
In addition, when the population was restricted to women with normal AGP values or when 
AGP was added to the model, the relationship between BMI and low serum ferritin 
remained largely unchanged. After adjusting for AGP in the model, the AOR for overweight 
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and obese women did not meaningfully change. This is in contrast to Ausk and Ioannou in 
which including CRP in the model with serum Fe status markers decreased the association 
between BMI and Fe status by 30–50 %(18); however, this may be related to the use of a 
different inflammation indicator. In Cepeda-Lopez et al., obesity no longer independently 
predicted Fe deficiency when CRP was added to the model(17). Although AGP has been 
shown to be useful in adjusting for the acute-phase response in chronic infection(6), we show 
a lack of impact on the relationship between obesity and Fe deficiency in our population. 
The continued influence of BMI on serum ferritin, independent of AGP, may be due to other 
inflammatory events that are not signalled by AGP, or it may be through a currently 
unknown mechanism.
The current study had several strengths. The data set was a nationally representative sample 
of women with children under 5 years of age in a developing country setting. Low serum 
ferritin prevalence was approximately twice that of a similar US population (26·1% v. 
13·6%)(44). Inflammation was measured through AGP, a marker of low-grade, chronic 
inflammation(6), which may be an appropriate choice for assessing inflammation associated 
with overweight and obesity. The analysis took into account the complex sample design of 
the survey.
There were also several limitations in the study. Only one marker of Fe status was measured 
in this population. While serum ferritin is the recommended indicator for assessing Fe 
deficiency by WHO(7), its role as an acute-phase protein makes assessing Fe deficiency in a 
population with inflammation or infection challenging. Measuring additional indicators that 
are less affected by inflammation may be useful. Underweight women were excluded due to 
small sample size and women interviewed were from households with pre-school children, 
which may not be representative of all women of childbearing age in Nicaragua. There was 
no information on dietary intake or parasitic infections available, which may also influence 
Fe status. Dietary Fe is a primary determining factor of body Fe stores(7) and in this case it 
was not possible to compare dietary Fe intakes across BMI groups or in relation to low 
serum ferritin. The study was cross-sectional and therefore temporal associations could not 
be examined.
Overall, in this population of reproductive-age women, obese women had a lower 
prevalence of low serum ferritin and this lower prevalence was independent of inflammation 
as measured by AGP. Obesity is an independent predictor of serum ferritin even when 
controlling for the inflammatory marker AGP. Measuring height and weight is common in 
nutrition surveys in both developing and developed country settings, although Fe deficiency 
prevalence is not always reported across BMI categories. Regularly reporting this 
information would be useful to allow further examination of the impact of weight status on 
Fe status. Further studies in different populations should continue to explore the possible 
additional impact of inflammation on this relationship. It may also be important to collect 
data on anthropometry in Fe supplementation trials, as BMI has been shown to affect Fe 
absorption(45–47). Documenting the prevalence of Fe deficiency across BMI categories 
should be considered when describing the prevalence of Fe deficiency in a given population.
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